Skip to content


Your cart is empty

Clean ingredients. Backed by science. Tested for safety and efficacy.


Ascents has the only functional fragrance formulas developed for healthcare and based on verified clinical research.

Nontoxic & Chemical Free

All Ascents formulations are free from parabens, sulfates, and other harmful chemicals

Farm-to-bottle Traceability

Every step is meticulously monitored for unparalleled product purity and quality

100% Pure & Natural

Ascents is made with a proprietary 100% pure essential oil formula and contain no fillers

Ascents was founded to promote well-being

Aeroscena, the parent company of Ascents, was founded in 2010 by CEO Mark Kohoot while advising Dr. Michael Roizen, Chief Wellness Officer at the Cleveland Clinic. Together, they recognized the need to raise the status of aromatherapy to medical-grade standards through rigorous quality criteria along with clinical research and testing in healthcare institutions.

We deliver promised health outcomes that go beyond aroma

Through strategic collaborations with renowned institutions, our formulas have undergone independent and rigorous scientific scrutiny to ensure their efficacy. The commitment to clinical validation underscores our dedication to providing tangible, measurable benefits. As a result, customers can trust that each product has been thoroughly tested to deliver the promised therapeutic outcomes.

The first gel-based delivery system to maximize scent function

The patented Gel-based polymerized essential oil is cold-fusion processed to retain ingredient integrity, maximizes scent impact and eliminate spillage or mess. The gels, enriched with natural ingredients, release fragrances gradually, infusing the surroundings with therapeutic benefits and creating an immersive atmosphere.


Reduce Nausea, Pain & Anxiety in Palliative Care Patients

A pilot study tested Nausea Relief No. 44, Focus No. 04, and Calm No. 34 for reducing symptoms in pediatric palliative care patients. All three formulas significantly reduced targeted symptoms, and the positive results were published in the Cambridge University Press journal Palliative and Supportive Care.

Frequently Asked Questions